More vaccines must be developed to tackle antimicrobial-resistant (AMR) bacterial pathogens, and countries must make better use of the ones currently available, the World Health Organization (WHO) said on Tuesday.
The UN agency has released its first-ever report on the pipeline of vaccines currently in development, geared at guiding further investment and research.
Antimicrobial resistance occurs when bacteria, viruses, fungi, and parasites change over time and no longer respond to…
